Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasm Metastasis × Sentinel Lymph Node Biopsy × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Endometrial Neoplasms 3 Uterine Cervical Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Triple Negative Breast Neoplasms 1 Pediatric Patients With Solid Tumors 1 Lymphedema 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Eyelid Sebaceous Gland Carcinoma 1 Cervical Adenocarcinoma 1 Carcinoma, Ductal 1 Breast Neoplasms, Male 1 Breast Carcinoma In Situ 1

Interventions

Gemcitabine 36 pembrolizumab 28 Paclitaxel 28 Nivolumab 28 Capecitabine 28 Bevacizumab 27 Fluorouracil 26 Oxaliplatin 25 Docetaxel 25 Leucovorin 22 Cyclophosphamide 22 Cisplatin 22 aldesleukin 19 Radiosurgery 17 Carboplatin 17 Interleukin-2 16 fludarabine phosphate 15 fludarabine 15 Irinotecan 15 Cetuximab 14 Trastuzumab 13 Prednisone 13 Ipilimumab 13 Pemetrexed 12 Fulvestrant 12 Everolimus 12 Panitumumab 11 Magnetic Resonance Spectroscopy 11 130-nm albumin-bound paclitaxel 10 aflibercept 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡